Optimizing the binding of fullerene inhibitors of the HIV-1 protease through predicted increases in hydrophobic desolvation

被引:181
作者
Friedman, SH
Ganapathi, PS
Rubin, Y
Kenyon, GL
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
[2] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA
关键词
D O I
10.1021/jm970689r
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We have developed and applied a computational strategy to increase the affinity of fullerene-based inhibitors of the HIV protease. The result is a similar to 50-fold increase in affinity from previously tested fullerene compounds. The strategy is based on the design of derivatives which may potentially increase hydrophobic desolvation upon complex formation, followed by the docking of the hypothetical derivatives into the HIV protease active site and assessment of the model complexes so formed. The model complexes are generated by the program DOCK and then analyzed for desolvated hydrophobic surface. The amount of hydrophobic surface desolvated was compared with a previously tested compound, and if this amount was significantly greater, it was selected as a target. Using this approach, two targets were identified and synthesized, using two different synthetic approaches: a diphenyl C-60 alcohol (5) based on a cyclopropyl derivative of Bingel (Chem. Ber. 1993, 226, 1957-1959) and a diisopropyl cyclohexyl C-60 alcohol (4a) as synthesized by Ganapathi et al. (J. Org. Chem. 1995, 60, 2954-2955). Both showed tighter binding than the originally tested compound (diphenethylaminosuccinate methano-C-60, K-i = 5 mu M) with K-i values of 103 and 150 nM, respectively. In addition to demonstrating the utility of this approach, it shows that simple modification of fullerenes can result in high-affinity ligands of the HIV protease, for which they are highly complementary in structure and chemical nature.
引用
收藏
页码:2424 / 2429
页数:6
相关论文
共 23 条
[1]   CYCLOPROPYLATION OF FULLERENES [J].
BINGEL, C .
CHEMISCHE BERICHTE-RECUEIL, 1993, 126 (08) :1957-1959
[2]   Tissue sites of uptake of C-14-labeled C-60 [J].
BullardDillard, R ;
Creek, KE ;
Scrivens, WA ;
Tour, JM .
BIOORGANIC CHEMISTRY, 1996, 24 (04) :376-385
[3]   NEW PROMISE IN COMBINATORIAL CHEMISTRY - SYNTHESIS, CHARACTERIZATION, AND SCREENING OF SMALL-MOLECULE LIBRARIES IN SOLUTION [J].
CARELL, T ;
WINTNER, EA ;
SUTHERLAND, AJ ;
REBEK, J ;
DUNAYEVSKIY, YM ;
VOUROS, P .
CHEMISTRY & BIOLOGY, 1995, 2 (03) :171-183
[4]  
Czarnik AW, 1996, ACCOUNTS CHEM RES, V29, P112, DOI 10.1021/ar950256n
[5]   THE HIV-1 PROTEASE AS A THERAPEUTIC TARGET FOR AIDS [J].
DEBOUCK, C .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (02) :153-164
[6]  
FRANZ A, 1996, FULLERENES P SERIES, V3, P1326
[7]   INHIBITION OF THE HIV-1 PROTEASE BY FULLERENE DERIVATIVES - MODEL-BUILDING STUDIES AND EXPERIMENTAL-VERIFICATION [J].
FRIEDMAN, SH ;
DECAMP, DL ;
SIJBESMA, RP ;
SRDANOV, G ;
WUDL, F ;
KENYON, GL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (15) :6506-6509
[8]   SEQUENTIAL DOUBLE-MICHAEL ADDITIONS OF DIENOLATES WITH C-60 - RAPID ACCESS TO STERICALLY CONGESTED BUCKMINSTERFULLERENE DERIVATIVES WITH DEFINED STEREOCHEMISTRY [J].
GANAPATHI, PS ;
FRIEDMAN, SH ;
KENYON, GL ;
RUBIN, Y .
JOURNAL OF ORGANIC CHEMISTRY, 1995, 60 (10) :2954-2955
[9]   Orientational sampling and rigid-body minimization in molecular docking revisited: On-the-fly optimization and degeneracy removal [J].
Gschwend, DA ;
Kuntz, ID .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1996, 10 (02) :123-132
[10]  
HIRSCH MS, 1993, NEW ENGL J MED, V328, P1686, DOI 10.1056/NEJM199306103282307